Please Wait
Applying Filters...
menu
    • menu
    Fermion-PSE
    News
    Green chemistry at Fermion

    20 Aug 2024

    // PRESS RELEASE

    Fermion has completed first investment for new Mfg capacity for APIs

    12 Mar 2024

    // PRFESS RELEASE

    Ami Organics inks agreement with Fermion for two additional APIs

    19 Dec 2023

    // INDIAN PHARMA POST

    Data Compilation
    #PharmaFlow

    Fermion VB

    Contact Supplier

    Website

    Bio-Europe 2024

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    Menu

    Fermion Oy

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 14-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxymethyl)phenol

    02 29,10-Dehydro Folitixorin Chloride

    03 1N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide

    04 1N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

    05 1N-benzyl-6-(4-phenyl-butoxy)hexan-1-amine hydrochloride

    06 1methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

    07 1methyl 2-amino-3-hydroxypropanoate hydrochloride

    08 1±2-amino-3-hydroxypropanehydrazide hydrochloride

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxy...

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    89365-50-4
    Salmeterol Xinafoate
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    01

    4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxymethyl)phenol

    Finland
    Bio-Europe 2024
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxy...

    CAS Number : 89365-50-4

    End Use API : Salmeterol Xinafoate

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    9,10-Dehydro Folitixorin Chloride

    Intermediate Web Link

    Market Place

    804563-04-0
    Levoleucovorin Calcium
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    02

    9,10-Dehydro Folitixorin Chloride

    Finland
    Bio-Europe 2024
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    9,10-Dehydro Folitixorin Chloride

    CAS Number : 804563-04-0

    End Use API : Levoleucovorin Calcium

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    9,10-Dehydro Folitixorin Chloride

    Intermediate Web Link

    Market Place

    804563-04-0
    Calcium Folinate
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    03

    9,10-Dehydro Folitixorin Chloride

    Finland
    Bio-Europe 2024
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    9,10-Dehydro Folitixorin Chloride

    CAS Number : 804563-04-0

    End Use API : Calcium Folinate

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-c...

    Intermediate Web Link

    Market Place

    1168152-07-5
    Nintedanib Esylate
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    04

    methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

    Finland
    Bio-Europe 2024
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-c...

    CAS Number : 1168152-07-5

    End Use API : Nintedanib Esylate

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    methyl 2-amino-3-hydroxypropanoate hydrochloride

    Intermediate Web Link

    Market Place

    5619-04-5
    Benserazide Hydrochloride
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    05

    methyl 2-amino-3-hydroxypropanoate hydrochloride

    Finland
    Bio-Europe 2024
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    methyl 2-amino-3-hydroxypropanoate hydrochloride

    CAS Number : 5619-04-5

    End Use API : Benserazide Hydrochloride

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-methoxyphenyl)pro...

    Intermediate Web Link

    Market Place

    73573-87-2
    Formoterol Fumarate
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    06

    N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide

    Finland
    Bio-Europe 2024
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-methoxyphenyl)pro...

    CAS Number : 73573-87-2

    End Use API : Formoterol Fumarate

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

    Intermediate Web Link

    Market Place

    262368-30-9
    Nintedanib Esylate
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    07

    N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

    Finland
    Bio-Europe 2024
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

    CAS Number : 262368-30-9

    End Use API : Nintedanib Esylate

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-benzyl-6-(4-phenyl-butoxy)hexan-1-amine hydrochloride

    Intermediate Web Link

    Market Place

    163923-18-0
    Salmeterol Xinafoate
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    08

    N-benzyl-6-(4-phenyl-butoxy)hexan-1-amine hydrochloride

    Finland
    Bio-Europe 2024
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    N-benzyl-6-(4-phenyl-butoxy)hexan-1-amine hydrochloride

    CAS Number : 163923-18-0

    End Use API : Salmeterol Xinafoate

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ±2-amino-3-hydroxypropanehydrazide hydrochloride

    Intermediate Web Link

    Market Place

    55819-71-1
    Benserazide Hydrochloride
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    09

    ±2-amino-3-hydroxypropanehydrazide hydrochloride

    Finland
    Bio-Europe 2024
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    ±2-amino-3-hydroxypropanehydrazide hydrochloride

    CAS Number : 55819-71-1

    End Use API : Benserazide Hydrochloride

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Fermion Oy and get a quotation

    Fermion Oy is a supplier offers 39 products (APIs, Excipients or Intermediates).

    Find a price of Alprazolam bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find a price of Azathioprine bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find a price of Formoterol Fumarate bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find a price of Hydroxychloroquine Sulphate bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find a price of Irinotecan Hydrochloride bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find a price of Mercaptopurine bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find a price of Methotrexate bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find a price of Sodium Cromoglicate bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find a price of Buspirone Hydrochloride bulk with DMF, CEP offered by Fermion Oy

    Find a price of Carbidopa bulk with DMF, CEP offered by Fermion Oy

    Find a price of Dexmedetomidine Hydrochloride bulk with DMF, JDMF offered by Fermion Oy

    Find a price of Entacapone bulk with DMF, CEP offered by Fermion Oy

    Find a price of Fluoxetine Hydrochloride bulk with DMF, CEP offered by Fermion Oy

    Find a price of Flutamide bulk with DMF, CEP offered by Fermion Oy

    Find a price of Nadolol bulk with DMF, JDMF offered by Fermion Oy

    Find a price of Nitrofurantoin bulk with DMF, CEP offered by Fermion Oy

    Find a price of Propafenone Hydrochloride bulk with DMF, CEP offered by Fermion Oy

    Find a price of Quetiapine Hemifumarate bulk with DMF, CEP offered by Fermion Oy

    Find a price of Toremifene Citrate bulk with DMF, JDMF offered by Fermion Oy

    Find a price of Benserazide Hydrochloride bulk with CEP offered by Fermion Oy

    Find a price of Budesonide bulk with CEP offered by Fermion Oy

    Find a price of Cabozantinib bulk with DMF offered by Fermion Oy

    Find a price of Diltiazem Hydrochloride bulk with DMF offered by Fermion Oy

    Find a price of Glipizide bulk with DMF offered by Fermion Oy

    Find a price of Levosimendan bulk with DMF offered by Fermion Oy

    Find a price of Methotrexate bulk with DMF offered by Fermion Oy

    Find a price of Nintedanib Esylate bulk with DMF offered by Fermion Oy

    Find a price of Nitrofurantoin bulk with DMF offered by Fermion Oy

    Find a price of Ospemifene bulk with DMF offered by Fermion Oy

    Find a price of Quetiapine Hemifumarate bulk with DMF offered by Fermion Oy

    Find a price of Salmeterol Xinafoate bulk with CEP offered by Fermion Oy

    Find a price of Tamsulosin bulk with JDMF offered by Fermion Oy

    Find a price of Tolnaftate bulk with DMF offered by Fermion Oy

    Find a price of Trazodone Hydrochloride bulk with DMF offered by Fermion Oy

    Find a price of Treosulfan bulk with DMF offered by Fermion Oy

    Find a price of Dabrafenib Mesylate bulk offered by Fermion Oy

    Find a price of Osimertinib Mesylate bulk offered by Fermion Oy

    Find a price of Rucaparib Camsylate bulk offered by Fermion Oy

    Find a price of Vismodegib bulk offered by Fermion Oy